Bloomberg -- Bionor Pharma ASA is proceeding with development of its experimental HIV vaccine even after it failed to keep patients off antiviral drugs in an early trial.
Bloomberg -- Bionor Pharma ASA is proceeding with development of its experimental HIV vaccine even after it failed to keep patients off antiviral drugs in an early trial.